Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Protein Translocation in Patients With Beta-Oxidation Disorders

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2000 by Office of Rare Diseases (ORD).
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Washington University School of Medicine
Information provided by:
Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier:
NCT00004348
First received: October 18, 1999
Last updated: June 23, 2005
Last verified: January 2000

October 18, 1999
June 23, 2005
September 1995
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00004348 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Protein Translocation in Patients With Beta-Oxidation Disorders
Not Provided

OBJECTIVES:

I. Characterize inheritance patterns of mutations in patients with beta-oxidation disorders.

PROTOCOL OUTLINE:

Patients undergo clinical and molecular analysis of beta-oxidation enzyme metabolism. The evaluation includes a urinary metabolite profile, and DNA and familial studies.

Observational
Primary Purpose: Screening
Not Provided
Not Provided
Not Provided
Not Provided
  • Beta-Oxidation Disorder
  • Peroxisomal Disorders
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
20
Not Provided
Not Provided

PROTOCOL ENTRY CRITERIA:

Beta-oxidation disorder, including: Medium-chain acyl-coenzyme A dehydrogenase deficiency Long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency Very-long-chain acyl-coenzyme A dehydrogenase deficiency Short-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency Long-chain 3-ketoacyl-coenzyme A thiolase deficiency Trifunctional protein deficiency Patient age: 1 day and over

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00004348
199/11907, WUSM-880075R
Not Provided
Not Provided
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Washington University School of Medicine
Study Chair: Arnold W. Strauss Washington University School of Medicine
Office of Rare Diseases (ORD)
January 2000

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP